Positions

Overview

  • Dr. Jane Schwebke is a Professor of Medicine who also has a joint appointment in Epidemiology in the UAB School of Public Health and serves as Medical Director of the Jefferson County Department of Health STD Clinic.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.Lancet Infectious Diseases.  18:1251-1259. 2018
    2018 Mycoplasma genitalium Infection in Kenyan and US WomenSexually Transmitted Diseases.  45:514-521. 2018
    2018 Defining the Urethritis Syndrome in Men Using Patient Reported Symptoms.Sexually Transmitted Diseases.  45:e40-e42. 2018
    2018 Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis.Journal of Clinical Microbiology.  56. 2018
    2018 Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence among Men and Women Determined by Nucleic Acid Amplification TestingSexually Transmitted Diseases.  45:e23-e24. 2018
    2018 In Vitro Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole.Antimicrobial Agents and Chemotherapy.  62. 2018
    2018 Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis.Sexual Health.  15:61-67. 2018
    2018 Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.Future Microbiology.  13:507-524. 2018
    2018 A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.Journal of Women's Health.  27:492-497. 2018
    2017 A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.American Journal of Obstetrics and Gynecology.  217:678.e1-678.e9. 2017
    2017 Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.Obstetrics and Gynecology.  130:379-386. 2017
    2017 Clinical Validation of a Test for the Diagnosis of Vaginitis.Obstetrics and Gynecology.  130:181-189. 2017
    2017 Meatal Swabs Contain Less Cellular Material and Are Associated with a Decrease in Gram Stain Smear Quality Compared to Urethral Swabs in Men.Journal of Clinical Microbiology.  55:2249-2254. 2017
    2017 Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.Expert Review of Molecular Diagnostics.  17:303-306. 2017
    2017 Sexually Transmitted Infection Risk among Women Is Not Fully Explained by Partner Numbers.Southern Medical Journal.  110:161-167. 2017
    2017 Sexually transmitted infections: challenges ahead.Lancet Infectious Diseases.  17:e235-e279. 2017
    2016 Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis.Sexually Transmitted Diseases.  43:599-602. 2016
    2016 Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses.Journal of Infectious Diseases.  214 Suppl 1:S1-S5. 2016
    2016 Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.Sexually Transmitted Diseases.  43:483-488. 2016
    2016 Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.Journal of Infectious Diseases.  213:1932-1937. 2016
    2016 Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.Sexually Transmitted Diseases.  43:369-373. 2016
    2016 Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases.Clinical Infectious Diseases.  62:531-536. 2016
    2015 A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.Clinical Infectious Diseases.  61 Suppl 8:S837-S848. 2015
    2015 Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.Clinical Infectious Diseases.  61:601-606. 2015
    2015 Management of Pelvic Inflammatory Disease in Selected U.S. Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011.Sexually Transmitted Diseases.  42:429-433. 2015
    2015 A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis.Sexually Transmitted Diseases.  42:376-381. 2015
    2015 Accuracy of Self-Report of Sexual Activity among Adolescent Girls: Implications for Interpretation of Vaginal Flora Patterns.mBio.  6:e00819. 2015
    2015 Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.Journal of Infectious Diseases.  211:1875-1882. 2015
    2015 Editorial commentary: women who have sex with women: a unique population for studying the pathogenesis of bacterial vaginosis.Clinical Infectious Diseases.  60:1054-1056. 2015
    2014 Association between BVAB1 and high Nugent scores among women with bacterial vaginosis.Diagnostic Microbiology and Infectious Disease.  80:321-323. 2014
    2014 Reply to Hickey and Forney.Journal of Infectious Diseases.  210:1683-1684. 2014
    2014 Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.Clinical Infectious Diseases.  59:834-841. 2014
    2014 Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model.Journal of Infectious Diseases.  210:338-343. 2014
    2014 ESwab as an optional collection device for use with the Affirm VPIII microbial test system.Journal of Clinical Microbiology.  52:1698-1700. 2014
    2014 Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system.Journal of Clinical Microbiology.  52:885-889. 2014
    2014 Lack of evidence for sexual transmission of genital Candida species among women who have sex with women: a mixed methods study.Sexually Transmitted Infections.  90:165-170. 2014
    2014 Prevalence of Gardnerella vaginalis among women with lactobacillus-predominant vaginal flora.Sexually Transmitted Infections.  90:61-63. 2014
    2014 Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposure.Sexually Transmitted Diseases.  41:58-60. 2014
    2013 Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis.Microbiome.  1:29. 2013
    2013 Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women.Journal of Clinical Microbiology.  51:3694-3699. 2013
    2013 Diagnostic rates differ on the basis of the number of read days with the use of the InPouch culture system for Trichomonas vaginalis screening.Journal of Clinical Microbiology.  51:3875-3876. 2013
    2013 Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.Sexually Transmitted Diseases.  40:865-869. 2013
    2013 Bacterial vaginosis among African American women who have sex with women.Sexually Transmitted Diseases.  40:751-755. 2013
    2013 Intravaginal metronidazole/miconazole for the treatment of vaginal trichomoniasis.Sexually Transmitted Diseases.  40:710-714. 2013
    2013 The clinical spectrum of Trichomonas vaginalis infection and challenges to management.Sexually Transmitted Infections.  89:423-425. 2013
    2013 Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic.Sexually Transmitted Infections.  89:514-518. 2013
    2013 Prevalence and treatment outcome of cervicitis of unknown etiology.Sexually Transmitted Diseases.  40:379-385. 2013
    2013 Gardnerella vaginalis: Still a Prime Suspect in the Pathogenesis of Bacterial Vaginosis.Current Infectious Disease Reports.  15:130-135. 2013
    2013 HIV testing among patients infected with Neisseria gonorrhoeae: STD Surveillance Network, United States, 2009-2010.AIDS and Behavior.  17:1205-1210. 2013
    2013 Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis.PLoS ONE.  8:e80254. 2013
    2012 Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy.Journal of Infectious Diseases.  206:357-365. 2012
    2012 Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis.Journal of Clinical Microbiology.  50:2321-2329. 2012
    2012 Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships.Sexually Transmitted Diseases.  39:556-558. 2012
    2012 Retention of clinical trial participants in a study of nongonococcal urethritis (NGU), a sexually transmitted infection in men.Controlled Clinical Trials.  33:606-610. 2012
    2012 Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010.Emerging Infectious Diseases.  18:939-943. 2012
    2012 Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?Diagnostic Microbiology and Infectious Disease.  73:16-20. 2012
    2012 HPV vaccine implementation in STD clinics--STD Surveillance Network.Sexually Transmitted Diseases.  39:32-34. 2012
    2011 Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.Journal of Clinical Microbiology.  49:4106-4111. 2011
    2011 Trichomonas vaginalis genital infections: progress and challenges.Clinical Infectious Diseases.  53 Suppl 3:S160-S172. 2011
    2011 Bacterial vaginosis is associated with variation in dietary indices.Journal of Nutrition.  141:1698-1704. 2011
    2011 Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern american STD clinic.Sexually Transmitted Diseases.  38:672-674. 2011
    2011 Tinidazole vs metronidazole for the treatment of bacterial vaginosis.American Journal of Obstetrics and Gynecology.  204:211.e1-211.e6. 2011
    2011 Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial.Clinical Infectious Diseases.  52:163-170. 2011
    2010 Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.Journal of Infectious Diseases.  202:1907-1915. 2010
    2010 Association between periodontal disease, bacterial vaginosis, and sexual risk behaviours.Journal of Clinical Periodontology.  37:888-893. 2010
    2010 A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.Sexually Transmitted Diseases.  37:392-396. 2010
    2010 Race of male sex partners and occurrence of bacterial vaginosis.Sexually Transmitted Diseases.  37:184-190. 2010
    2010 Personal hygienic behaviors and bacterial vaginosis.Sexually Transmitted Diseases.  37:94-99. 2010
    2009 Bacterial vaginosis: are we coming full circle?Journal of Infectious Diseases.  200:1633-1635. 2009
    2009 The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis.Sexually Transmitted Diseases.  36:336-340. 2009
    2009 New concepts in the etiology of bacterial vaginosis.Current Infectious Disease Reports.  11:143-147. 2009
    2009 Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.American Journal of Obstetrics and Gynecology.  200:188.e1-188.e7. 2009
    2009 Prevalence of Gardnerella vaginalis in male sexual partners of women with and without bacterial vaginosis.Sexually Transmitted Diseases.  36:92-94. 2009
    2008 Partnership concurrency status and condom use among women diagnosed with Trichomonas vaginalis.Women's Health Issues.  18:369-374. 2008
    2008 Viability of Trichomonas vaginalis in Copan universal transport medium and eSwab transport medium.Journal of Clinical Microbiology.  46:3134-3135. 2008
    2008 A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis.American Journal of Epidemiology.  168:188-196. 2008
    2008 Association of Mobiluncus curtisii with recurrence of bacterial vaginosis.Sexually Transmitted Diseases.  35:611-613. 2008
    2008 Lactational amenorrhea as a risk factor for group a streptococcal vaginitis.Clinical Infectious Diseases.  46:e112-e115. 2008
    2008 The polymicrobial hypothesis of bacterial vaginosis causation: a reassessment.International Journal of STD and AIDS.  19:152-154. 2008
    2008 Trichomoniasis in a young girl: Nonsexual transmission is possible - But not likelyConsultant.  48:202. 2008
    2008 Why do women douche? A longitudinal study with two analytic approaches.Annals of Epidemiology.  18:65-73. 2008
    2007 Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age.Sexually Transmitted Diseases.  34:954-959. 2007
    2007 Natural history of asymptomatic bacterial vaginosis in a high-risk group of women.Sexually Transmitted Diseases.  34:876-877. 2007
    2007 The association between Trichomonas vaginalis infection and level of vaginal lactobacilli, in nonpregnant women.Journal of Infectious Diseases.  196:1102-1107. 2007
    2007 Dietary intake of selected nutrients affects bacterial vaginosis in women.Journal of Nutrition.  137:2128-2133. 2007
    2007 The Women's Health II Medical Education Network _Part 1: Understanding bacterial vaginosis: diagnosis, treatment, and improved outcomes.Journal of Family Practice.  56:S1-S6. 2007
    2007 A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases.American Journal of Obstetrics and Gynecology.  196:517.e1-517.e6. 2007
    2007 A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis.Clinical Infectious Diseases.  44:213-219. 2007
    2007 Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.Clinical Infectious Diseases.  44:13-22. 2007
    2006 Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.Antimicrobial Agents and Chemotherapy.  50:4209-4210. 2006
    2006 Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis.Journal of Clinical Microbiology.  44:3994-3999. 2006
    2006 A pilot study of vaginal flora changes with randomization to cessation of douching.Sexually Transmitted Diseases.  33:610-613. 2006
    2006 Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.American Journal of Obstetrics and Gynecology.  194:1283-1289. 2006
    2006 Local and systemic cytokine levels in relation to changes in vaginal flora.Journal of Infectious Diseases.  193:556-562. 2006
    2006 The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort.American Journal of Obstetrics and Gynecology.  194:381-386. 2006
    2005 Trichomoniasis in adolescents: a marker for the lack of a public health response to the epidemic of sexually transmitted diseases in the United States.Journal of Infectious Diseases.  192:2036-2038. 2005
    2005 Partner notification methods for African American men being treated for trichomoniasis: a consideration of main men, Second Hitters, and Third Players.Medical anthropology newsletter.  19:383-401. 2005
    2005 Association between genital tract cytomegalovirus infection and bacterial vaginosis.Journal of Infectious Diseases.  192:1727-1730. 2005
    2005 Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases.Sexually Transmitted Diseases.  32:654-658. 2005
    2005 Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases.Journal of Infectious Diseases.  192:1315-1317. 2005
    2005 Use of vaginal polymorphonuclear to epithelial cell ratios for the prediction of preterm birth.Obstetrics and Gynecology.  105:139-144. 2005
    2005 Vulvovaginal symptoms in women with bacterial vaginosisObstetrical and Gynecological Survey.  60:26-28. 2005
    2004 Trichomoniasis.Clinical Microbiology Reviews.  17:794-803. 2004
    2004 Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections.Sexually Transmitted Infections.  80:401-405. 2004
    2004 Vulvovaginal symptoms in women with bacterial vaginosis.Obstetrics and Gynecology.  104:267-272. 2004
    2004 Performance of a new, rapid assay for detection of Trichomonas vaginalis.Journal of Clinical Microbiology.  42:2940-2943. 2004
    2004 Predictors of bacterial vaginosis in adolescent women who douche.Sexually Transmitted Diseases.  31:433-436. 2004
    2004 Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic.AIDS Research and Human Retroviruses.  20:577-583. 2004
    2004 A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis.Sexually Transmitted Diseases.  31:236-238. 2004
    2003 Gynecologic consequences of bacterial vaginosis.Obstetrics and Gynecology Clinics of North America.  30:685-694. 2003
    2003 High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.Journal of Infectious Diseases.  188:465-468. 2003
    2002 Findings from STD screening of adolescents and adults entering corrections facilities: implications for STD control strategies.Sexually Transmitted Diseases.  29:834-839. 2002
    2002 An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis.Acta pathologica et microbiologica Scandinavica.  110:811-818. 2002
    2002 Improved detection by DNA amplification of Trichomonas vaginalis in males.Journal of Clinical Microbiology.  40:3681-3683. 2002
    2002 Update of trichomoniasis.Sexually Transmitted Infections.  78:378-379. 2002
    2002 Cost-effective screening for trichomoniasis.Emerging Infectious Diseases.  8:749. 2002
    2002 Hepatitis, syphilis, and HIV sentinel surveillance in Mongolia 1999-2000.Sexually Transmitted Infections.  78:223-224. 2002
    2002 Screening women in jails for chlamydial and gonococcal infection using urine tests: feasibility, acceptability, prevalence, and treatment rates.Sexually Transmitted Diseases.  29:271-276. 2002
    2002 Interrelationships of bacterial vaginosis and cervical inflammation.Sexually Transmitted Diseases.  29:59-64. 2002
    2001 Antimicrobial resistance among Neisseria gonorrhoeae isolates from Ulaanbaatar, Mongolia.Sexually Transmitted Infections.  77:463. 2001
    2001 Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HIV/STD/hepatitis/genital tract infections.Sexually Transmitted Infections.  77:344-350. 2001
    2001 Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens.Journal of Clinical Microbiology.  39:3197-3199. 2001
    2001 Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.American Journal of Obstetrics and Gynecology.  185:163-165. 2001
    2001 Prevalence of Mobiluncus spp among women with and without bacterial vaginosis as detected by polymerase chain reaction.Sexually Transmitted Diseases.  28:195-199. 2001
    2001 Role of Vaginal Flora As a Barrier to HIV Acquisition.Current Infectious Disease Reports.  3:152-155. 2001
    2001 Influence of the normal menstrual cycle on vaginal microflora.Clinical Infectious Diseases.  32:325. 2001
    2000 Asymptomatic bacterial vaginosis: response to therapy.American Journal of Obstetrics and Gynecology.  183:1434-1439. 2000
    2000 Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.Journal of Clinical Microbiology.  38:3585-3588. 2000
    2000 InTray GC medium versus modified Thayer-Martin agar plates for diagnosis of gonorrhea from endocervical specimens.Journal of Clinical Microbiology.  38:3825-3826. 2000
    2000 Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.American Journal of Public Health.  90:1615-1618. 2000
    2000 Screening for latent tuberculosis in sexually transmitted disease clinics.Clinical Infectious Diseases.  30:986. 2000
    2000 Bacterial Vaginosis.Current Infectious Disease Reports.  2:14-17. 2000
    2000 Erratum: Mid-trimester vaginal biological markers of infection predictive of lower genital tract fetal fibronectin (FFN) (American Journal of Obstetrics and Gynecology (2000) 182 (1-2))American Journal of Obstetrics and Gynecology.  182:751. 2000
    1999 Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens.Journal of Clinical Microbiology.  37:3583-3585. 1999
    1999 Correlation of behaviors with microbiological changes in vaginal flora.Journal of Infectious Diseases.  180:1632-1636. 1999
    1999 Viability of Trichomonas vaginalis in transport medium.Journal of Clinical Microbiology.  37:3749-3750. 1999
    1999 From the Centers for Disease Control and Prevention. High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers--Chicago, Birmingham, and San Francisco, 1998.Journal of the American Medical Association.  282:1417-1418. 1999
    1999 Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center.Sexually Transmitted Diseases.  26:496-499. 1999
    1999 Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis.Journal of Clinical Microbiology.  37:2369-2370. 1999
    1999 Self-reported sexual activity and condom use among symptomatic clients attending STD clinics.Sexually Transmitted Diseases.  26:286-290. 1999
    1998 Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group.Journal of Infectious Diseases.  178:1795-1798. 1998
    1998 Sexually transmitted diseases in Ulaanbaatar, Mongolia.International Journal of STD and AIDS.  9:354-358. 1998
    1998 Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.American Journal of Medicine.  104:28-32. 1998
    1997 Bacterial vaginosis - More questions than answersSexually Transmitted Infections.  73:333-334. 1997
    1997 Bacterial vaginosis--more questions than answers.Genitourinary medicine.  73:333-334. 1997
    1997 Effect of concurrent lower genital tract infections on cervical cancer screeningSexually Transmitted Infections.  73:383-386. 1997
    1997 Effect of concurrent lower genital tract infections on cervical cancer screening.Genitourinary medicine.  73:383-386. 1997
    1997 Self-treatment patterns among clients attending sexually transmitted disease clinics and the effects of self-treatment on STD symptom duration. The Study Group.Sexually Transmitted Diseases.  24:372-377. 1997
    1997 Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis.Journal of Clinical Microbiology.  35:1618-1619. 1997
    1997 Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic.Sexually Transmitted Diseases.  24:181-184. 1997
    1997 The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora.Sexually Transmitted Diseases.  24:236-239. 1997
    1996 Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.Antimicrobial Agents and Chemotherapy.  40:2775-2780. 1996
    1996 Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.Obstetrics and Gynecology.  88:573-576. 1996
    1996 Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.Obstetrics and Gynecology.  88:573-576. 1996
    1996 Humoral antibody to Mobiluncus curtisii, a potential serological marker for bacterial vaginosis.Clinical and Diagnostic Laboratory Immunology.  3:567-569. 1996
    1996 Tuberculosis screening in a sexually transmitted diseases clinic.Sexually Transmitted Diseases.  23:299-303. 1996
    1996 Comparison of DNA probe (Gen-Probe) with culture for the detection of Neisseria gonorrhoeae in an urban STD programmeSexually Transmitted Infections.  72:108-110. 1996
    1996 Comparison of DNA probe (Gen-Probe) with culture for the detection of Neisseria gonorrhoeae in an urban STD programme.Genitourinary medicine.  72:108-110. 1996
    1995 Metronidazole: utilization in the obstetric and gynecologic patient.Sexually Transmitted Diseases.  22:370-376. 1995
    1995 Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991.Antimicrobial Agents and Chemotherapy.  39:917-920. 1995
    1995 Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis.Infectious Diseases in Obstetrics & Gynecology.  3:119-122. 1995
    1994 Decreased susceptibility to penicillin G and Tet M plasmids in genital and anorectal isolates of Neisseria meningitidis.Antimicrobial Agents and Chemotherapy.  38:1661-1663. 1994
    1994 Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users.Journal of Infectious Diseases.  169:962-967. 1994
    1993 The validity of injecting drug users' self-reports about sexually transmitted diseases: a comparison of survey and serological data.Addiction.  88:673-680. 1993
    1992 Evaluation of Syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens.Diagnostic Microbiology and Infectious Disease.  15:663-668. 1992
    1991 Use of a urine enzyme immunoassay as a diagnostic tool for Chlamydia trachomatis urethritis in men.Journal of Clinical Microbiology.  29:2446-2449. 1991
    1991 Identification of two new antigenic subgroups within the genus Mobiluncus.Journal of Clinical Microbiology.  29:2204-2208. 1991
    1991 Risk for HIV infection among health care workers. Nine questions physicians often ask.Consultant.  31:29-30. 1991
    1990 Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women.Journal of Clinical Microbiology.  28:2473-2476. 1990
    1990 Trends in sexually transmitted diseases in homosexually active men in King County, Washington, 1980-1990.Sexually Transmitted Diseases.  17:211-215. 1990
    1990 Pneumonia due to Legionella micdadei in bone marrow transplant recipients.Reviews of infectious diseases.  12:824-828. 1990
    1990 Demonstration of heterogeneity among the antigenic proteins of Mobiluncus species.Journal of Clinical Microbiology.  28:463-468. 1990
    1987 Profile of the uremic neutrophil.Life support systems : the journal of the European Society for Artificial Organs.  10:287-290. 1987

    Chapter

    Year Title Altmetric
    2014 Trichomonas vaginalis.  3161-3164.e1. 2014
    2013 Vaginal Infections.  473-483. 2013

    Research Overview

  • Dr. Schwebke’s laboratory has emphasized microbiologic studies of vaginal flora in women including Trichomonas vaginalis and bacterial vaginosis (BV). Dr. Schwebke’s recent work has included the development of new methodologies for evaluation of changes in vaginal flora over time, new perspectives on the origins and management of women with BV, and evaluation of new diagnostic tests (culture methods, PCR) for trichomoniasis. She has also recently guided development of laboratory efforts to evaluate and carry out surveillance for nosocomial infections caused by resistant bacteria within UAB Hospital. Major ongoing research efforts include studies of interactions between BV and risk for other STDs; characterization of the make-up and shifts in normal vaginal flora in women; prevention of recurrent BV; and the epidemiology and optimal management strategies for trichomoniasis in males. Her research is funded through the UAB STD CRC (E.W. Hook, PI, J.R. Schwebke Co-PI); and 3 funded RO-1 grants (J.R. Schwebke, P.I.).
  • Principal Investigator On

  • Private Grant  awarded by MYCOVIA PHARMACEUTICAL, INC. 2018 - 2020
  • Randomized Controlled Trial of Treatment of Male Partners of Women with BV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • The UAB Infectious Diseases Training Grant  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • The UAB STI CRC - Project 2: Strain Diversity among Gardnerella: Association with Progression to BV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Slide Scoring in the Investigation between the Vaginal Microbiota and Uterine Fibroids  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2018
  • Private Grant  awarded by CURATEK PHARMACEUTICALS 2015 - 2018
  • Private Grant  awarded by SCYNEXIS 2017 - 2018
  • Private Grant  awarded by GAGE DEVELOPMENT COMPANY, LLC 2017 - 2018
  • A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess The Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for The Treatment of Bacterial Vaginosis  awarded by Duke University 2018
  • Private Grant  awarded by LABORATORY CORPORATION OF AMERICA HOLDINGS 2016 - 2017
  • Private Grant  awarded by STARPHARMA 2014 - 2017
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW 2016 - 2017
  • Private Grant  awarded by BD DIAGNOSTICS 2015 - 2017
  • Private Grant  awarded by FLORA BIOSCIENCE 2016 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2014 - 2016
  • Private Grant  awarded by VIAMET PHARMACEUTICALS, INC. - NEW 2014 - 2016
  • Private Grant  awarded by ELITECH GROUP MOLECULAR 2014 - 2016
  • Private Grant  awarded by QUIDEL CORPORATION 2015 - 2016
  • Private Grant  awarded by CEPHEID 2014 - 2016
  • Private Grant  awarded by ALFA-WASSERMAN, INC. 2015 - 2016
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2015
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2015
  • Private Grant  awarded by BIOHELIX CORPORATION 2013 - 2015
  • Private Grant  awarded by BD DIAGNOSTICS 2014 - 2015
  • Private Grant  awarded by WATSON LABORATORIES, INC. 2014 - 2015
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC 2014
  • Private Grant  awarded by CEPHEID 2013 - 2014
  • Private Grant  awarded by GEN-PROBE, INC. 2013 - 2014
  • Private Grant  awarded by CEPHEID 2014
  • Regional AIDS Education and Training Centers Program  awarded by Emory University 2010 - 2014
  • Regional AIDS Education and Training Centers Program  awarded by Emory University 2010 - 2014
  • RCT of Treatment of Male Partners of Women with Recurrent Bacterial Vaginosis  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2012 - 2014
  • A Double-Blind Randomized Trial of Monthly Treatment with Topical Metronidazole and Miconazole Co-Formulated Pessaries vs Placebo for Preventing Vaginal Infection in HIV-Seronegative Women DMID# 09-0070  awarded by University of California, San Francisco 2012 - 2013
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2012 - 2013
  • Private Grant  awarded by COPAN DIAGNOSTICS, INC 2012 - 2013
  • Private Grant  awarded by EMBIL LLAC SANAYA LTD 2011 - 2013
  • UAB Infectious Diseases Training Grant  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2008 - 2013
  • Private Grant  awarded by MEDICIS PHARMACEUTICAL CORPORATION 2012 - 2013
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2013
  • A Double-Blind Randomized Trial of Monthly Treatment with Topical Metronidazole and Miconazole Co-formulated Pessaries vs Placebo for Preventing Vaginal Infections in HIV-Seronegative Women DMID #09-0070  awarded by University of California, San Francisco 2010 - 2013
  • Private Grant  awarded by GEN-PROBE, INC. 2011 - 2012
  • Private Grant  awarded by METHYLGENE INC. 2011 - 2012
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2011 - 2012
  • Private Grant  awarded by LABORATORY CORPORATION OF AMERICA HOLDINGS 2011 - 2012
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2010 - 2011
  • Private Grant  awarded by BD DIAGNOSTICS 2010 - 2011
  • The Microbial Ecology of Bacterial Vaginosis: A Fine Scale Resolution Metagenomic Analysis  awarded by University of Maryland 2009 - 2011
  • Private Grant  awarded by GEN-PROBE, INC. 2009 - 2010
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2009 - 2010
  • Private Grant  awarded by SAVYON DIAGNOSTICS 2007 - 2010
  • STD Surveillance Network (SSuN)  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2008 - 2009
  • Investigator On

  • Private Grant  awarded by ABBOTT MOLECULAR 2018 - 2020
  • Admin Core: Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200001 Task Area 1 Task Order 1 - Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200003 Task Area 2 Task Order 1 - Clinical Trial Implementation-DMID (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200008 Task Area 1 Task Order 8 - Protocol Development, Implementation and Analysis for A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200009 Task Area 1 Task Order 7 - Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200011 Task Area 1 Task Order 10 - Sexually Transmitted Infections Clinical Trials Group (STI CTG) TASK AREA 1 TASK ORDER 10 Protocol Development, Implementation and Analysis for Treatment of Gardnerella Vaginalis Vaginal Colonization with Amoxicillin  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200012 Task Area 1 Task Order 11 - Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • Private Grant  awarded by CEPHEID 2018 - 2019
  • Private Grant  awarded by RHEONIX, INC. 2014 - 2019
  • Private Grant  awarded by ATLAS GENETICS 2017 - 2019
  • The UAB STI CRC - DiSCIS Clinical Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Pathogenesis of Bacterial Vaginosis in Women Who Have Sex with Women  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by SPEEDX PTY. LTD. 2018 - 2019
  • Private Grant  awarded by ABBOTT MOLECULAR 2018 - 2019
  • Rectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women  awarded by University of California, San Francisco 2018 - 2019
  • Private Grant  awarded by LUMINEX CORPORATION 2018 - 2019
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2017 - 2018
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2017 - 2018
  • Private Grant  awarded by HOLOGIC, INC. 2017 - 2018
  • Private Grant  awarded by CLICK DIAGNOSTICS 2016 - 2018
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2016 - 2018
  • Trichomonas Vaginalis Repeat Infections Among HIV-Negative Women  awarded by TULANE UNIVERSITY 2013 - 2018
  • Private Grant  awarded by LUMINEX CORPORATION 2017
  • Private Grant  awarded by BECKMAN COULTER, INC. 2015 - 2017
  • Mechanisms and Correlates of Immune Protection Against Genital Chlamydia in Humans  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2017
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2016 - 2017
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2016 - 2017
  • Private Grant  awarded by HOLOGIC, INC. 2016 - 2017
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2015 - 2016
  • Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing: Concurrence in Non-Clinical Settings vs. Clinical Settings  awarded by University of California, San Francisco 2014 - 2015
  • JCDH Contract NO: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH 2014 - 2015
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2013 - 2015
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2004 - 2015
  • Private Grant  awarded by HOLOGIC, INC. 2014
  • STD/HIV Prevention Training Center  awarded by CDC - NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION 2011 - 2014
  • Private Grant  awarded by BD DIAGNOSTICS 2011 - 2014
  • Private Grant  awarded by SANOFI PASTEUR LIMITED 2009 - 2013
  • Education And Training

  • Doctor of Medicine, Northwestern University
  • Full Name

  • Jane Schwebke
  • Blazerid

  • schwebke